Target

Application

Progress

Collaborator/Sponsor

P. Vivax
P. Falciparum

Novel anti-malarials

Drug Repositioning;
Design of NCEs

Johns Hopkins Bloomberg School of Public Health; Bill & Melinda Gates Foundation GCE award

Trypanosoma brucei

Human African Trypanosomiasis

Experimentally Validated Compounds

University of Georgia; NIH SBIR phase I grant 1R43AI114078-01

Mycobacterium tuberculosis

Tuberculosis

Experimentally Validated Compounds

Nrf2

Neurodegeneration

Design of NCEs

NeuRho Farmaceutica Inc.; Michael J Fox Foundation for Parkinson's Research

FAAH; MAGL

Schizophrenia

Experimentally Validated Compounds

University of Texas Health Science Center - San Antonio; NIH SBIR phase I grant 1R43MH101892-01

Tau

Neurodegeneration

Experimentally Validated Compounds

Renin

Hypertension diagnostics

Experimental Validation

 EU Fund for Regional Development